| __timestamp | Ligand Pharmaceuticals Incorporated | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 22570000 | 2652041 |
| Thursday, January 1, 2015 | 24378000 | 2361587 |
| Friday, January 1, 2016 | 26621000 | 4472869 |
| Sunday, January 1, 2017 | 28653000 | 5030957 |
| Monday, January 1, 2018 | 37734000 | 4988941 |
| Tuesday, January 1, 2019 | 41884000 | 5196412 |
| Wednesday, January 1, 2020 | 64435000 | 6652774 |
| Friday, January 1, 2021 | 57483000 | 18418247 |
| Saturday, January 1, 2022 | 70062000 | 24827066 |
| Sunday, January 1, 2023 | 52790000 | 41896408 |
| Monday, January 1, 2024 | 15488619 |
Cracking the code
In the competitive landscape of pharmaceuticals, effective cost management is crucial. Over the past decade, Ligand Pharmaceuticals Incorporated has consistently outpaced Opthea Limited in managing Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ligand's SG&A expenses grew by approximately 133%, peaking in 2022. In contrast, Opthea's expenses surged by over 1,500% during the same period, reflecting its aggressive expansion strategy.
This data underscores the contrasting strategies of these companies, with Ligand focusing on steady growth and Opthea on rapid expansion.
Cost Management Insights: SG&A Expenses for AstraZeneca PLC and Opthea Limited
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Opthea Limited
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Exelixis, Inc. vs Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Corcept Therapeutics Incorporated and Opthea Limited
Operational Costs Compared: SG&A Analysis of Opthea Limited and PTC Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Opthea Limited and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Opthea Limited or Xencor, Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and Ligand Pharmaceuticals Incorporated
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Ligand Pharmaceuticals Incorporated and Agios Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?